Get more replies from employers
Send a job-specific resume in minutes.
Zealand Pharma A/S in Denmark seeks a Lead Analytical Specialist to steer late-stage analytical development and provide scientific direction across development and lifecycle projects. You will coordinate with CDMOs and external partners while driving validation and regulatory support for CMC activities.
The role requires strong leadership, mentoring abilities, and extensive GMP/regulatory experience in peptide-centric analytics, shaping strategies across Drug Substance and Drug Product
Does it excite you to lead late-stage analytical development for innovative peptide-based medicines, and do you have a strong technical background in analytical science? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.
As Lead Analytical Specialist, you will lead late-stage analytical development and provide scientific and technical direction across a broad range of activities in Development and Life Cycle Management projects. Given our collaboration with Contract Development and Manufacturing Organizations (CDMO), effective coordination with external partners is a significant aspect of this role.
You will be joining a highly experienced team of experts within CMC Development, acting as a technical point of reference and mentor for colleagues. We value a collaborative and supportive atmosphere where we achieve great results together.
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let's bond and be bold.
For further information, please contact Director, Head of Drug Substance & Analysis, Iben Almar Meier; imeier@zealandpharma.com.
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data-driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health. To date, more than ten Zealand Pharma-invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts. Learn more at www.zealandpharma.com.